The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proactive, automated monitoring of uncontrolled symptoms in prostate cancer survivors across the cancer control continuum.
 
Miguel Muniz
No Relationships to Disclose
 
Daniel S Childs
Employment - Mayo Clinic
Honoraria - International Centers for Precision Oncology Foundation; IntrinsiQ; MJH Life Sciences; Targeted Oncology
Consulting or Advisory Role - Janssen Biotech (Inst); Novartis (Inst)
Research Funding - Janssen Biotech (Inst)
Travel, Accommodations, Expenses - Prostate Cancer Foundation
 
Kathryn Jean Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Veronica Grzegorczyk
No Relationships to Disclose
 
Deirdre R. Pachman
No Relationships to Disclose
 
Alicia K. Morgans
Honoraria - Advanced Accelerator Applications; Astellas Pharma; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Clovis Oncology; Exelixis; Genentech; Janssen; Janssen; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Exelixis; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Myovant Sciences; Myriad Genetics; Novartis; Sanofi
Research Funding - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Dendreon; Genentech; Myovant Sciences; Sanofi; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Sanofi; Telix Pharmaceuticals
 
Ewan Kemar Cobran
No Relationships to Disclose
 
Joan M. Griffin
Research Funding - Exact Sciences (Inst)
 
Ashley Wilder Smith
No Relationships to Disclose
 
Kurt Kroenke
No Relationships to Disclose
 
Charles L. Loprinzi
Consulting or Advisory Role - Bexion; Bexion; Bexion; Bexion; Denali Therapeutics; Denali Therapeutics; Disarm Therapeutics; Galendia; Genentech; Grunenthal; Hengrui Pharmaceutical; Hengrui Pharmaceutical ; Metys Pharmaceuticals; Metys Pharmaceuticals; Mitsubishi Tanabe Pharma; Neuropathix; Neuropathix; Neuropathix; NKMax; OnQuality Pharmaceuticals; Osmol Therapeutics; Veloxis; Veloxis; Vevro
Research Funding - Bristol-Myers Squibb (Inst)
 
Brian Addis Costello
Speakers' Bureau - Clinical Care Options/NCCN (Inst)
Research Funding - GlaxoSmithKline/Novartis (Inst)
 
Jacob Orme
Consulting or Advisory Role - NaNotics
Patents, Royalties, Other Intellectual Property - Patents regarding PD-L1 cleavage and immunotherapy resistance in multiple cancers. (Inst)
 
Irbaz Bin Riaz
No Relationships to Disclose
 
A. Oliver Sartor
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Cardinal Health; Clarity Pharmaceuticals; Convergent Therapeutics; Fusion Pharmaceuticals; Lilly; POINT Biopharma; PSMA Therapeutics; Ratiopharm; Telix Pharmaceuticals; United Health Group
Honoraria - Intellisphere; Lantheus Medical Imaging; Novartis
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; ARTbio; Astellas Pharma; AstraZeneca; Bavarian Nordic; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Clarity Pharmaceuticals; Clovis Oncology; Constellation Pharmaceuticals; Dendreon; EMD Serono; Fusion Pharmaceuticals; Hengrui Therapeutics; Isotopen Technologien; Janssen; MacroGenics; Medscape; Merck; Morphimmune; Myovant Sciences; Myriad Genetics; Noria Therapeutics; Northstar; Novartis; Noxopharm; Pfizer; Point Biopharma; Progenics; Ratio; Sanofi; Telix Pharmaceuticals; TEmpus; TeneoBio; Tessa Therapeutics; Theragnostics
Research Funding - Advanced Accelerator Applications (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Endocyte (Inst); InVitae (Inst); Janssen; Lantheus Medical Imaging (Inst); Merck (Inst); Progenics; Sanofi (Inst); SOTIO
Patents, Royalties, Other Intellectual Property - Koochekpour, Sartor AO, inventors. Saposin C and receptors as targets for treatment of benign and malignant disorders. US patent awarded January 23, 2007 (patent no. 7,166,691).
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Johnson & Johnson; Lantheus Medical Imaging; Progenics; Sanofi
 
Sandra A. Mitchell
No Relationships to Disclose
 
Andrea L. Cheville
No Relationships to Disclose